Molecular imaging offers insight into chemo-brain
A newly published literature review sheds light on how nuclear medicine brain imaging can help evaluate the biological changes that cause chemotherapy-related cognitive impairment (CRCI), commonly known as chemo-brain. Armed with this information, patients can understand better the changes in their cognitive status during and after treatment.
from Top Health News -- ScienceDaily https://ift.tt/sueBXAW
from Top Health News -- ScienceDaily https://ift.tt/sueBXAW